Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol - Potential Applications in Induction of Labour and Treatment of Postpartum Hemorrhage

NCT03434444 is registered in ClinicalTrials.gov with Samuel Lunenfeld Research Institute, Mount Sinai Hospital as lead sponsor.

NCT NCT03434444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03434444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol - Potential Applications in Induction of Labour and Treatment of Postpartum Hemorrhage
Lead sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 8, 2017
Completion date
August 20, 2022
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage